Skip to content
The Vaccine Group Logo
  • Home
  • About
  • Diseases
  • Science
  • Pipeline
  • News
  • Contact
  • Home
  • About
  • Diseases
  • Science
  • Pipeline
  • News
  • Contact

TVG’s CEO discusses the impact of a new £500,000 IUK/Defra grant

TVG’s CEO Jeremy Salt was interviewed by Stephen Gunnion of Proactive this week for the online news service Reach. In the

Read More »
17 November 2026

TVG and APHA awarded £500,000 to advance BRSV vaccine programme

The Vaccine Group (TVG) and the Animal and Plant Health Agency (APHA) have been awarded £500,000 through Defra’s Farming Innovation

Read More »
9 November 2026

TVG BRSV vaccine study now available on bioRxiv

The Vaccine Group (TVG) is pleased to announce that the full study underpinning its BRSV vaccine results is now available

Read More »
21 October 2026

The Vaccine Group Welcomes Two New Directors to its Board

The Vaccine Group (TVG) is pleased to announce the appointment of Neil Crabb and Professor Laura Bowater, MBE, to its

Read More »
22 June 2026

TVG CEO contributes expertise to international animal health research discussions in Ottawa

The Vaccine Group was pleased to see TVG CEO Dr Jeremy Salt contribute expertise to the recent STAR IDAZ International

Read More »
21 May 2026

TVG’s BRSV vaccine recognised among the UK’s major animal research breakthroughs in 2025

The Vaccine Group’s bovine respiratory syncytial virus (BRSV) vaccine programme has been recognised in the 2025 Animal Research Breakthroughs Review published by

Read More »
10 February 2026

TVG CEO Jeremy Salt discusses S suis vaccine progress

Read More »
26 January 2026

TVG Streptococcus suis success underpins vaccine delivery platform potential

TVG is delighted to announce that a vaccine candidate to tackle Streptococcus suis (“S.suis”) in pigs developed with University of

Read More »
19 January 2026
Two calves in field with buttercups

The Vaccine Group shows outstanding performance of its BRSV vaccine candidate in calves

The Vaccine Group (TVG) has demonstrated outstanding results in a cattle challenge trial conducted by the UK government’s Animal and

Read More »
3 November 2025
Page1 Page2 Page3 Page4 Page5
↑

The Vaccine Group (TVG) develops herpesvirus-based viral-vector vaccines for livestock and companion animals, with expanding applications in biotherapeutics.

Linkedin

More Pages

  • Resources
  • Careers (No Current Vacancies)
  • Sitemap
  • Resources
  • Careers (No Current Vacancies)
  • Sitemap

Legal

  • Privacy Policy
  • Cookie Policy
  • Terms & Conditions

Lab Address

Derriford Research Facility

Plymouth Science Park

Plymouth, Devon

PL6 8BU

info@thevaccinegroup.com

Registered Address

The Officers’ Mess

Royston Road

Duxford

Cambridgeshire

CB22 4QH

The Vaccine Group 2026 © All Rights Reserved